FindTrial
Sign In

Study in patients of increased blood cholesterol

Dyslipidemia: an observational study - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/11/007486
Enrollment
100
Registered
2016-11-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients of hypercholesterolemia eligible for statin therapy

Interventions

Control Intervention1: Atorvastatin & Rosuvastatin: Atorvastatin 20 mg/ Rosuvastatin 5 mg as decided by prescribing physician in a routine clinical care for 6 weeks

Sponsors

All India Institute of Medical Sciences AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients of hypercholesterolemia who are eligible candidate for statin therapy

Exclusion criteria

Exclusion criteria: Any adult patients of hypercholesterolemia who are not eligible candidate for statin therapy

Design outcomes

Primary

MeasureTime frame
percentage reduction in plasma LDL cholesterolTimepoint: from baseline to 6 weeks—

Secondary

MeasureTime frame
percentage reduction in TC, TGs and percentage increase in HDLTimepoint: from baseline to 6 weeks—

Countries

India

Contacts

Public ContactDr Pramod Kumar Sharma

All India Institute of Medical Sciences (AIIMS)

pramod309@gmail.com8003996894

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026